Belvedere Trading LLC Bria Cell Therapeutics Corp. Call Options Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 08, 2023	SELL	$5.72 - $7.58 $37,752 - $50,028	-6,600 Reduced 36.07%	11,700 $75,000
Q1 2023 May 15, 2023	SELL	$4.59 - $7.99 $85,374 - $148,614	-18,600 Reduced 50.41%	18,300 $136,000
Q4 2022 Feb 14, 2023	BUY	$4.28 - $6.03 $157,932 - $222,507	36,900 New	36,900 $161,000
Q2 2022 Jul 21, 2022	BUY	$4.28 - $11.9 $125,832 - $349,860	29,400 Added 166.1%	47,100 $293,000
Q1 2022 Apr 20, 2022	SELL	$5.91 - $10.14 $300,819 - $516,126	-50,900 Reduced 74.2%	17,700 $139,000

Q4 2021 Jan 25, 2022	BUY	$7.1 - $10.61 $487,060 - $727,846	68,600 New	68,600 $491,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.